HomeClinical TrialsAvailable Clinical Trials

Available Kidney Clinical Trials

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724).

Email: askrpci@roswellpark.org

A Phase I/II Study of the HDAC Inhibitor LBH589 in Combination with the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell Carcinoma
A Phase I/II Study of High Dose Interleukin 2, Aldesleukin, in Combination with the Histone Deacetylase Inhibitor Entinostat in Patients with Metastatic Renal Cell Carcinoma
A Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects with Localized or Locally Advanced RCC Following Nephrectomy
Phase I/II Study of Dalteparin, A Low Molecular Weight Heparin (LMWH), in Combination with Sunitinub (SU11248), an Oral, Selective Multitareted Tyrosine Kinase Inhibitor, as First Line Treatment, in Patients with Metastati...

Cancer Talk Blog
Good Day Sunshine? Vitamin D and Cancer

Can "the sunshine vitamin" play a role in preventing and treating cancer? Find out what Roswell Park Cancer Institute scientists and clinicians are learning about the inspiring potential of vitamin D for the future of cancer treatment. Featuring an interview with graduate student Sarah Mazzilli and Pamela Hershberger, PhD of Roswell Park's Department of Pharmacology and...

Read more

Latest Video

Ask A Question

Do you have a cancer question you’d like RPCI cancer experts to address? Submit a topic for consideration.

New to RSS? Learn More

close